Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Sep 27, 2010
Financial News
Arterial Remodeling completes venture financing
...le Roi, France Business: Cardiovascular Date completed: 9/21/10 Type: Venture financing Raised: $8.5 million Investors:
Matignon
...
Read More
BioCentury
|
May 10, 2010
Finance
Focused radiation
...round for the French cancer radiotherapy company. Masseran Gestion also co-led the round. Existing investors
Matignon
...
Read More
BioCentury
|
May 10, 2010
Financial News
Nanobiotix completes venture financing
...completed: 5/4/10 Type: Venture financing Raised: $11 million Investors: CIC Vizille Capital Innovation; Masseran Gestion;
Matignon
...
Read More
BioCentury
|
May 5, 2010
Financial News
Nanobiotix raises $11 million
...a series C round co-led by CIC Vizille Capital Innovation and Masseran Gestion. Existing investors
Matignon
...
Read More
BioCentury
|
May 1, 2007
Financial News
Nautilus raises EUR 8.4 million
...in a private round. Investors included Creabilis Biotech; Edmond de Rothschild Investment Partners; Auriga Partners;
Matignon
...
Read More
BioCentury
|
Apr 30, 2007
Finance
Ebb & Flow
...E8.4 million ($11.3 million) in a round of venture funding from existing investors Creabilis Biotech,
Matignon
...
Read More
BioCentury
|
Dec 4, 2006
Politics, Policy & Law
Expanding the French model
...$89.8 million) in four funds: Auriga III, Ventech III,
Matignon
Technologies II and I-Source III.
Matignon
...
Read More
BioCentury
|
Mar 3, 2003
Emerging Company Profile
Corporate Profile
...Employees: 38 Funds raised: E14.5 million ($15.6 million) Investors: Societé Generale Asset Management, LCF Rothschild,
Matignon
...
Read More
Items per page:
10
1 - 8 of 8
BioCentury
|
Sep 27, 2010
Financial News
Arterial Remodeling completes venture financing
...le Roi, France Business: Cardiovascular Date completed: 9/21/10 Type: Venture financing Raised: $8.5 million Investors:
Matignon
...
Read More
BioCentury
|
May 10, 2010
Finance
Focused radiation
...round for the French cancer radiotherapy company. Masseran Gestion also co-led the round. Existing investors
Matignon
...
Read More
BioCentury
|
May 10, 2010
Financial News
Nanobiotix completes venture financing
...completed: 5/4/10 Type: Venture financing Raised: $11 million Investors: CIC Vizille Capital Innovation; Masseran Gestion;
Matignon
...
Read More
BioCentury
|
May 5, 2010
Financial News
Nanobiotix raises $11 million
...a series C round co-led by CIC Vizille Capital Innovation and Masseran Gestion. Existing investors
Matignon
...
Read More
BioCentury
|
May 1, 2007
Financial News
Nautilus raises EUR 8.4 million
...in a private round. Investors included Creabilis Biotech; Edmond de Rothschild Investment Partners; Auriga Partners;
Matignon
...
Read More
BioCentury
|
Apr 30, 2007
Finance
Ebb & Flow
...E8.4 million ($11.3 million) in a round of venture funding from existing investors Creabilis Biotech,
Matignon
...
Read More
BioCentury
|
Dec 4, 2006
Politics, Policy & Law
Expanding the French model
...$89.8 million) in four funds: Auriga III, Ventech III,
Matignon
Technologies II and I-Source III.
Matignon
...
Read More
BioCentury
|
Mar 3, 2003
Emerging Company Profile
Corporate Profile
...Employees: 38 Funds raised: E14.5 million ($15.6 million) Investors: Societé Generale Asset Management, LCF Rothschild,
Matignon
...
Read More
Items per page:
10
1 - 8 of 8
Previous page
Next page